DMRTC2
gene geneOn this page
Also known as DMRT7
Summary
DMRTC2 (DMRT like family C2, HGNC:13911) is a protein-coding gene on chromosome 19q13.2, encoding Doublesex- and mab-3-related transcription factor C2 (Q8IXT2). May be involved in sexual development.
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in cell differentiation; regulation of transcription by RNA polymerase II; and sex differentiation. Predicted to act upstream of or within heterochromatin organization; male meiosis I; and spermatid nucleus elongation. Predicted to be located in chromatin. Predicted to be active in nucleus.
Source: NCBI Gene 63946 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 53 total
- MANE Select transcript:
NM_001040283
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13911 |
| Approved symbol | DMRTC2 |
| Name | DMRT like family C2 |
| Location | 19q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DMRT7 |
| Ensembl gene | ENSG00000142025 |
| Ensembl biotype | protein_coding |
| OMIM | 614806 |
| Entrez | 63946 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 5 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000269945, ENST00000596258, ENST00000596660, ENST00000596827, ENST00000599022, ENST00000600017, ENST00000601660, ENST00000602098
RefSeq mRNA: 1 — MANE Select: NM_001040283
NM_001040283
CCDS: CCDS33034
Canonical transcript exons
ENST00000269945 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000951884 | 41850312 | 41850372 |
| ENSE00000951885 | 41850526 | 41850700 |
| ENSE00001164354 | 41851584 | 41852333 |
| ENSE00001309323 | 41848795 | 41848975 |
| ENSE00003010493 | 41845042 | 41845101 |
| ENSE00003536888 | 41847736 | 41847881 |
| ENSE00003537970 | 41848452 | 41848528 |
| ENSE00003546094 | 41847425 | 41847652 |
| ENSE00003613975 | 41849130 | 41849256 |
Expression profiles
Bgee: expression breadth broad, 53 present calls, max score 94.35.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1005 / max 114.5756, expressed in 3 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 176071 | 0.0680 | 3 |
| 176069 | 0.0189 | 3 |
| 176070 | 0.0136 | 3 |
Top tissues by expression
212 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 94.35 | gold quality |
| left testis | UBERON:0004533 | 93.50 | gold quality |
| testis | UBERON:0000473 | 91.33 | gold quality |
| sperm | CL:0000019 | 87.08 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.38 | gold quality |
| secondary oocyte | CL:0000655 | 84.42 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.60 | gold quality |
| oocyte | CL:0000023 | 73.86 | gold quality |
| adult organism | UBERON:0007023 | 72.47 | gold quality |
| buccal mucosa cell | CL:0002336 | 59.25 | gold quality |
| tibialis anterior | UBERON:0001385 | 55.01 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 53.84 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| blood | UBERON:0000178 | 53.45 | gold quality |
| pancreatic ductal cell | CL:0002079 | 53.33 | silver quality |
| deltoid | UBERON:0001476 | 51.16 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| quadriceps femoris | UBERON:0001377 | 48.89 | gold quality |
| vastus lateralis | UBERON:0001379 | 48.00 | gold quality |
| ileal mucosa | UBERON:0000331 | 47.44 | silver quality |
| colonic epithelium | UBERON:0000397 | 47.03 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| upper leg skin | UBERON:0004262 | 43.71 | silver quality |
| bone marrow | UBERON:0002371 | 43.69 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| muscle tissue | UBERON:0002385 | 41.85 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.78 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1479.1 | DMRTC2 | DMRT factors |
| MA1479.2 | DMRTC2 | DMRT factors |
JASPAR matrix evidence (PMIDs): PMID:25215497
miRNA regulators (miRDB)
26 targeting DMRTC2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-1343-3P | 99.89 | 66.78 | 1815 |
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-6857-5P | 99.87 | 65.32 | 985 |
| HSA-MIR-6752-3P | 99.72 | 66.71 | 1587 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-4743-3P | 99.62 | 68.12 | 2095 |
| HSA-MIR-5693 | 99.24 | 66.67 | 1106 |
| HSA-MIR-4520-2-3P | 99.14 | 69.28 | 1009 |
| HSA-MIR-4999-3P | 99.11 | 65.55 | 424 |
| HSA-MIR-3117-5P | 99.04 | 67.93 | 618 |
| HSA-MIR-500A-5P | 98.76 | 69.13 | 1241 |
| HSA-MIR-6804-3P | 98.72 | 64.82 | 852 |
| HSA-MIR-1261 | 98.62 | 68.10 | 896 |
| HSA-MIR-5581-3P | 98.55 | 70.31 | 1161 |
| HSA-MIR-4450 | 98.26 | 68.35 | 725 |
| HSA-MIR-6773-3P | 98.17 | 65.51 | 1213 |
| HSA-MIR-7850-5P | 98.12 | 67.28 | 1111 |
| HSA-MIR-6841-5P | 97.19 | 67.29 | 409 |
| HSA-MIR-215-3P | 97.02 | 68.01 | 1209 |
| HSA-MIR-711 | 96.60 | 65.75 | 528 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Dmrtc2 | ENSMUSG00000011349 |
| rattus_norvegicus | Dmrtc2 | ENSRNOG00000020109 |
| caenorhabditis_elegans | WBGENE00019521 | |
| caenorhabditis_elegans | WBGENE00022060 |
Paralogs (8): DMRT3 (ENSG00000064218), DMRT1 (ENSG00000137090), DMRTA2 (ENSG00000142700), DMRTB1 (ENSG00000143006), DMRT2 (ENSG00000173253), DMRTA1 (ENSG00000176399), DMRTC1B (ENSG00000184911), DMRTC1 (ENSG00000269502)
Protein
Protein identifiers
Doublesex- and mab-3-related transcription factor C2 — Q8IXT2 (reviewed: Q8IXT2)
All UniProt accessions (5): Q8IXT2, B4DX56, M0QZH7, M0R1Z9, M0R2D7
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in sexual development.
Subcellular location. Nucleus.
Tissue specificity. Expressed in testis and pancreas.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the DMRT family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IXT2-1 | 1 | yes |
| Q8IXT2-2 | 2 |
RefSeq proteins (1): NP_001035373* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001275 | DM_DNA-bd | Domain |
| IPR026607 | DMRT | Family |
| IPR031577 | DMRT-C1/C2_C | Domain |
| IPR036407 | DM_DNA-bd_sf | Homologous_superfamily |
Pfam: PF00751, PF15791
UniProt features (8 total): region of interest 2, splice variant 2, sequence conflict 2, chain 1, DNA-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IXT2-F1 | 60.70 | 0.20 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 61 (showing top):
GOBP_MALE_GAMETE_GENERATION, GOBP_ORGANELLE_FISSION, GOBP_NUCLEUS_ORGANIZATION, GOBP_MALE_MEIOSIS_I, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_SPERMATID_NUCLEUS_DIFFERENTIATION, GOBP_SEX_DIFFERENTIATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, GOBP_HETEROCHROMATIN_ORGANIZATION, AGCTCCT_MIR28, GOBP_MEIOTIC_CELL_CYCLE, GOCC_SEX_CHROMOSOME, LEIN_CEREBELLUM_MARKERS, GOCC_XY_BODY
GO Biological Process (7): male meiosis I (GO:0007141), spermatid nucleus elongation (GO:0007290), sex differentiation (GO:0007548), heterochromatin organization (GO:0070828), regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357), cell differentiation (GO:0030154)
GO Molecular Function (6): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), identical protein binding (GO:0042802), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), sequence-specific DNA binding (GO:0043565)
GO Cellular Component (3): chromatin (GO:0000785), XY body (GO:0001741), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| meiosis I | 1 |
| male meiotic nuclear division | 1 |
| male gamete generation | 1 |
| meiotic cell cycle | 1 |
| nucleus organization | 1 |
| spermatid nucleus differentiation | 1 |
| developmental process involved in reproduction | 1 |
| chromatin organization | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cellular developmental process | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| protein binding | 1 |
| cation binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| DNA binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| sex chromosome | 1 |
| condensed chromatin of inactivated sex chromosome | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
566 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DMRTC2 | LYPD4 | Q6UWN0 | 571 |
| DMRTC2 | C10orf120 | Q5SQS8 | 513 |
| DMRTC2 | SOX30 | O94993 | 483 |
| DMRTC2 | NCAPH | Q15003 | 479 |
| DMRTC2 | C5orf47 | Q569G3 | 477 |
| DMRTC2 | IQCF1 | Q8N6M8 | 459 |
| DMRTC2 | CCDC27 | Q2M243 | 444 |
| DMRTC2 | CCDC83 | Q8IWF9 | 441 |
| DMRTC2 | PKMYT1 | Q99640 | 424 |
| DMRTC2 | CDADC1 | Q9BWV3 | 421 |
| DMRTC2 | RCHY1 | Q96PM5 | 398 |
| DMRTC2 | ACCSL | Q4AC99 | 394 |
| DMRTC2 | RBBP8NL | Q8NC74 | 393 |
| DMRTC2 | SAXO1 | Q8IYX7 | 386 |
| DMRTC2 | DEFB112 | Q30KQ8 | 384 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| IRF9 | DMRTC2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TXNRD1 | DMRTC2 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (3): DMRTC2 (Proximity Label-MS), DMRTC2 (Two-hybrid), TXNRD1 (Two-hybrid)
ESM2 similar proteins: A0A5F9ZHS7, A1YGK1, A2T7E6, A8MZG2, O08574, O43593, O60393, O75593, O88621, O95231, P0C1T1, P0CG20, P20428, P97609, Q04667, Q17QR5, Q2KIS6, Q2M1V0, Q2T9Q7, Q32LE6, Q497V6, Q5JUK2, Q5M844, Q5RJB0, Q5TGS1, Q61645, Q61657, Q6ZMY3, Q6ZN32, Q6ZNG2, Q7RTU1, Q8BZW2, Q8CGW9, Q8IWN7, Q8IXT2, Q8IZ20, Q8N1L9, Q8N7G0, Q8N944, Q8N9Y4
Diamond homologs: A2A9A2, A2A9I7, A4QNP7, A6QQ94, A8TSS9, B0I1G7, B7ZS42, C0LZJ1, D4A218, F6W2R2, G5EEJ1, J7FCF0, O18214, P23023, P57690, P83758, P85119, Q18248, Q19291, Q2I327, Q2MJB4, Q32LE6, Q3LH63, Q4AE28, Q5UU75, Q5VZB9, Q6YHU8, Q71MM5, Q76L87, Q801F8, Q80WT2, Q8BG36, Q8CFG4, Q8CGW9, Q8IXT2, Q8JIR6, Q90WM5, Q96MA1, Q96SC8, Q9DFI0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
53 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1180 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:41847420:CCTA:C | acceptor_loss | 1.0000 |
| 19:41847421:CTA:C | acceptor_loss | 1.0000 |
| 19:41847423:A:AG | acceptor_gain | 1.0000 |
| 19:41847423:AG:A | acceptor_loss | 1.0000 |
| 19:41847424:G:GA | acceptor_gain | 1.0000 |
| 19:41847424:G:GC | acceptor_loss | 1.0000 |
| 19:41847424:GATCC:G | acceptor_gain | 1.0000 |
| 19:41847649:TCCT:T | donor_gain | 1.0000 |
| 19:41847651:CT:C | donor_gain | 1.0000 |
| 19:41847651:CTG:C | donor_loss | 1.0000 |
| 19:41847653:G:GG | donor_gain | 1.0000 |
| 19:41847653:GTG:G | donor_loss | 1.0000 |
| 19:41847654:TGAG:T | donor_loss | 1.0000 |
| 19:41848450:A:AG | acceptor_gain | 1.0000 |
| 19:41848450:AGCT:A | acceptor_gain | 1.0000 |
| 19:41848451:G:GG | acceptor_gain | 1.0000 |
| 19:41848451:GCTG:G | acceptor_gain | 1.0000 |
| 19:41850381:A:T | donor_gain | 1.0000 |
| 19:41850384:G:GT | donor_gain | 1.0000 |
| 19:41850448:G:GT | donor_gain | 1.0000 |
| 19:41847416:T:TA | acceptor_gain | 0.9900 |
| 19:41847424:GA:G | acceptor_gain | 0.9900 |
| 19:41847424:GAT:G | acceptor_gain | 0.9900 |
| 19:41847424:GATC:G | acceptor_gain | 0.9900 |
| 19:41847648:ATCCT:A | donor_gain | 0.9900 |
| 19:41847650:CCT:C | donor_gain | 0.9900 |
| 19:41847657:G:GG | donor_gain | 0.9900 |
| 19:41847734:AG:A | acceptor_gain | 0.9900 |
| 19:41847735:GG:G | acceptor_gain | 0.9900 |
| 19:41847735:GGGA:G | acceptor_gain | 0.9900 |
AlphaMissense
2325 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:41847561:T:A | C45S | 0.999 |
| 19:41847561:T:C | C45R | 0.999 |
| 19:41847562:G:C | C45S | 0.999 |
| 19:41847572:T:A | H48Q | 0.999 |
| 19:41847572:T:G | H48Q | 0.999 |
| 19:41847615:T:C | F63L | 0.999 |
| 19:41847617:C:A | F63L | 0.999 |
| 19:41847617:C:G | F63L | 0.999 |
| 19:41847552:T:C | C42R | 0.998 |
| 19:41847565:G:C | R46P | 0.998 |
| 19:41847639:T:C | C71R | 0.998 |
| 19:41847593:G:C | K55N | 0.997 |
| 19:41847593:G:T | K55N | 0.997 |
| 19:41847602:G:C | K58N | 0.997 |
| 19:41847602:G:T | K58N | 0.997 |
| 19:41847609:T:C | C61R | 0.997 |
| 19:41847615:T:A | F63I | 0.997 |
| 19:41847615:T:G | F63V | 0.997 |
| 19:41847616:T:C | F63S | 0.997 |
| 19:41847616:T:G | F63C | 0.997 |
| 19:41847630:T:C | C68R | 0.997 |
| 19:41847639:T:A | C71S | 0.997 |
| 19:41847640:G:C | C71S | 0.997 |
| 19:41847740:C:A | R77S | 0.997 |
| 19:41847754:G:A | M81I | 0.997 |
| 19:41847754:G:C | M81I | 0.997 |
| 19:41847754:G:T | M81I | 0.997 |
| 19:41847552:T:A | C42S | 0.996 |
| 19:41847553:G:A | C42Y | 0.996 |
| 19:41847553:G:C | C42S | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000189887 (19:41847796 A>G), RS1000560049 (19:41845743 C>G), RS1003742123 (19:41844359 C>T), RS1004270385 (19:41850172 A>C,G), RS1004332060 (19:41844100 A>T), RS1004380739 (19:41844317 G>A,T), RS1004643641 (19:41848490 C>A,T), RS1005010048 (19:41848737 C>T), RS1005306364 (19:41851349 G>A,T), RS1005363391 (19:41844920 C>T), RS1005687063 (19:41851576 G>A,C), RS1007721871 (19:41846121 G>T), RS1008061142 (19:41852822 G>A), RS1008438100 (19:41849152 C>G,T), RS1008723125 (19:41847890 C>A,T)
Disease associations
OMIM: gene MIM:614806 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010703_14 | Brain morphology (MOSTest) | 1.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | decreases expression, affects cotreatment | 2 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| Temozolomide | affects response to substance | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Carmustine | affects response to substance | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A1A1 | SEES3-1V human DMRTC2, clone1 | Embryonic stem cell | Male |
| CVCL_A1A2 | SEES3-1V human DMRTC2, clone2 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.